SEC Form 4
VolitionRx Limited (VNRX) insider trading
In the 12 months to Oct 26, 2026, one VNRX insider reported open-market purchases of $7.0K across 1 filing; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $7.0K
- 1 filing · Cameron John Reynolds, President and CEO
Who traded VNRX, and when
- Purchase
VNRX daily close from Oct 27, 2025 to Oct 26, 2026, between $0.17 and $8.98, last $0.18. 0 sale and 1 purchase filings by 1 insider, marked at their filing dates. Cameron John Reynolds, President and CEO: bought $7.0K across 1 filing, first filed Nov 17, 2025, last Nov 17, 2025.
Largest mark · tap a row for others
Cameron John Reynolds · President and CEO
Purchase $7,000
20,000 shares at $0.35 avg
Filed Nov 17, 2025
Close on filing date $6.32
Cameron John Reynolds · President and CEO
President and CEO
$7.0K boughtOpen-market trades
1 filing in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Cameron John Reynolds | President and CEO | — | $7.0K | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
| Cameron John Reynolds President and CEO | Purchase | 20,000 | $0.35 | $7.0K | 2,554,847 |
GET /stocks/filings/vX/form-4?tickers=VNRX&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"VNRX"
],
"issuer_cik": "0000093314",
"owner_cik": "0001340610",
"accession_number": "0001477932-25-008380",
"form_type": "4",
"filing_date": "2025-11-17",
"period_of_report": "2025-11-17",
"issuer_name": "VOLITIONRX LTD",
"issuer_trading_symbol": "VNRX",
"owner_name": "Reynolds Cameron John",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "President and CEO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 20000,
"transaction_price_per_share": 0.35,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 2554847,
"transaction_value": 7000,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
}
]
}
// trimmed to 1 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 45 records
- Tax withholding17 records
- Grants and awards28 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has VolitionRx Limited's CEO sold stock?
No. Jasmine Kway and Cameron John Reynolds and Salvatore Thomas Butera (CEOs) made no open-market sales filed as CEO in the last 12 months.
How current is VNRX’s insider data?
These are VNRX Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track VNRX insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for VNRX every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.